Want to see MREO full AI Analyst Report?
Mereo Biopharma Group Plc (MREO) Financial Statements
899 Followers
Mereo Biopharma Group Plc Financial Overview
Mereo Biopharma Group Plc's market cap is currently $45.17M. The company's EPS TTM is $-0.18; its P/E ratio is -1.55; Mereo Biopharma Group Plc is estimated to report earnings on November 17, 2026, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 500.00K | $ 0.00 | $ 10.00M | $ 0.00 | $ 49.21M |
| Gross Profit | $ 367.00K | $ 0.00 | $ 7.43M | $ 1.15M | $ 25.04M |
| Operating Income | $ -38.26M | $ 0.00 | $ -28.42M | $ -54.43M | ― |
| EBITDA | $ -40.47M | $ 1.09M | $ -26.06M | $ -37.87M | $ 25.49M |
| Net Income | $ -41.88M | $ 0.00 | $ -29.47M | $ -42.22M | $ 17.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 40.99M | $ 69.80M | $ 57.42M | $ 68.18M | $ 127.52M |
| Total Assets | $ 45.92M | $ 76.39M | $ 66.50M | $ 77.41M | $ 170.96M |
| Total Debt | $ 202.00K | $ 6.43M | $ 5.95M | $ 15.37M | $ 22.66M |
| Net Debt | $ -40.79M | $ -63.37M | $ -51.47M | $ -52.81M | $ -104.08M |
| Total Liabilities | $ 5.00M | $ 15.42M | $ 15.96M | $ 26.01M | $ 51.95M |
| Stockholders' Equity | $ 40.92M | $ 60.97M | $ 50.54M | $ 51.40M | $ 119.01M |
| Cash Flow | |||||
| Free Cash Flow | $ -30.99M | $ -33.53M | $ -21.55M | $ -48.83M | $ -7.79M |
| Operating Cash Flow | $ -30.97M | $ -32.83M | $ -21.13M | $ -48.82M | $ -7.07M |
| Investing Cash Flow | $ -20.00K | $ -699.00K | $ -419.00K | $ 1.99M | $ -568.20K |
| Financing Cash Flow | $ 327.00K | $ 46.15M | $ 7.97M | $ 200.00K | $ 104.80M |
Currency in USD
